PHARMA - PHARMA-Unusual Market Activity ("UMA") query by Bursa Securities
Announcement Type: Listing Circular
Company Name: PHARMANIAGA BERHAD
Stock Name: PHARMA
Date Announced: 18/06/2012
Announcement Detail:
Subject: PHARMA-Unusual Market Activity ("UMA") query by Bursa Securities
Contents: Bursa Malaysia Securities Berhad has on 18 June 2012 issued an UMA query on the trading of the Company's shares.
In this respect, investors are advised to take note of the Company's reply to the above UMA query which will be posted at Bursa Malaysia's website under the company announcements, http://announcements.bursamalaysia.com when making their investment decision.
The contents of the UMA query is as follows:-
We draw your attention to the consecutive limit up recently of your Company's shares.
In accordance with the Corporate Disclosure Policy on Response To Unusual Market Activity pursuant to paragraph 9.11 of the Main Market Listing Requirements of Bursa Malaysia Securities Berhad ("Main LR"), you are requested to furnish Bursa Malaysia Securities Berhad ("Bursa Securities") with an announcement for public release after making due enquiry with your directors and major shareholders seeking the cause of the unusual market activity in the Company's shares.
In this respect, you are also required to publicly confirm, amongst others, the following:-
1. whether there is any corporate development relating to your Group's business and affairs that has not been previously announced that may account for the unusual market activity including those in the stage of negotiation / discussion. If yes, kindly provide the details including the status of the corporate development to enable investors to make informed investment decision;
2. whether there is any rumour or report concerning the business and affairs of the Group that may account for the unusual market activity and in this respect, you are required to comply with paragraphs 9.09 and 9.10 of the Main LR;
3. whether you are aware of any other possible explanation to account for the unusual market activity; and
4. your compliance with the Main LR, in particular paragraph 9.03 of the Main LR on immediate disclosure obligations.
Please note that the contents of the announcement must be endorsed by the Board of Directors of the Company and the announcement must reach Bursa Securities immediately via Bursa LINK.
Company Name: PHARMANIAGA BERHAD
Stock Name: PHARMA
Date Announced: 18/06/2012
Announcement Detail:
Subject: PHARMA-Unusual Market Activity ("UMA") query by Bursa Securities
Contents: Bursa Malaysia Securities Berhad has on 18 June 2012 issued an UMA query on the trading of the Company's shares.
In this respect, investors are advised to take note of the Company's reply to the above UMA query which will be posted at Bursa Malaysia's website under the company announcements, http://announcements.bursamalaysia.com when making their investment decision.
The contents of the UMA query is as follows:-
We draw your attention to the consecutive limit up recently of your Company's shares.
In accordance with the Corporate Disclosure Policy on Response To Unusual Market Activity pursuant to paragraph 9.11 of the Main Market Listing Requirements of Bursa Malaysia Securities Berhad ("Main LR"), you are requested to furnish Bursa Malaysia Securities Berhad ("Bursa Securities") with an announcement for public release after making due enquiry with your directors and major shareholders seeking the cause of the unusual market activity in the Company's shares.
In this respect, you are also required to publicly confirm, amongst others, the following:-
1. whether there is any corporate development relating to your Group's business and affairs that has not been previously announced that may account for the unusual market activity including those in the stage of negotiation / discussion. If yes, kindly provide the details including the status of the corporate development to enable investors to make informed investment decision;
2. whether there is any rumour or report concerning the business and affairs of the Group that may account for the unusual market activity and in this respect, you are required to comply with paragraphs 9.09 and 9.10 of the Main LR;
3. whether you are aware of any other possible explanation to account for the unusual market activity; and
4. your compliance with the Main LR, in particular paragraph 9.03 of the Main LR on immediate disclosure obligations.
Please note that the contents of the announcement must be endorsed by the Board of Directors of the Company and the announcement must reach Bursa Securities immediately via Bursa LINK.
No comments:
Post a Comment